Inflammatory bowel disease: treatment and management
You must score at least 70% in this module to pass. Ensure you have read ‘Inflammatory bowel disease: treatment and management’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
0 of 15 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 15 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
What percentage of inflammatory bowel disease teams in the UK meet the standards for pharmacist involvement?CorrectIncorrect
In treatment for inflammatory bowel disease, ‘conventional therapy’ refers to which agents?CorrectIncorrect
Which of the statements regarding 5-ASA is true?CorrectIncorrect
What is recommended for patients who are refractory to 5-ASA and require stepping up to steroids?CorrectIncorrect
Budesonide and beclomethasone are which generation of corticosteroids?CorrectIncorrect
Which metabolite of mercaptopurine should be monitored following commencement of a thiopurine?CorrectIncorrect
Allopurinol is a xanthine oxidase inhibitor which prevents the breakdown of thiopurines to thiouric acid. What dose of allopurinol should be used in combination with low dose thiopurine to correct hypermethylation?CorrectIncorrect
Which anti-TNFs are licensed for both ulcerative colitis and Crohn’s disease?CorrectIncorrect
Combination anti-TNF and thiopurine therapy increases the risk of serious opportunistic infections. Prophylaxis with which agent should be considered?CorrectIncorrect
Which interleukins are inhibited by ustekinumab?CorrectIncorrect
Which of the following criteria is not a red flag when initiating tofacitinib?CorrectIncorrect
Which of the following drugs is not available as an intravenous/subcutaneous formulation?CorrectIncorrect
Patients taking vedolizumab should be counselled to look out for symptoms of which neurological disorder?CorrectIncorrect
Nutrient deficiencies are common in inflammatory bowel disease. Which micronutrients should be monitored and replaced?CorrectIncorrect
Patients receiving immunosuppressive drugs should avoid receiving live vaccines (e.g. the BCG vaccine) for how long after terminating treatment?CorrectIncorrect